SCHEMBL6988433

SCHEMBL6988433

C=Cc1ccc(C(=O)NCC(C(=O)NC2(C)C(=O)COC2C)c2ccc(O)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.35
TAS1R1 Q7RTX1 2/20 0.35
ESRRG P62508 1/20 0.33
PLD2 O14939 1/20 0.31
PLD1 Q13393 1/20 0.31
CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991034 0.90 TAS1R3 (0.34) TAS1R3TAS1R1PLD2PLD1
SCHEMBL6987871 0.89 CTSK (0.39) ESRRGCTSK
SCHEMBL6988403 0.88 KMT2A (0.35) PLD1CTSK
SCHEMBL6989542 0.88 TP53 (0.40) ESRRGCTSK
SCHEMBL6990082 0.87 MAPT (0.41) ESRRG
SCHEMBL6990056 0.87 OPRM1 (0.37)
SCHEMBL6988694 0.84 ATM (0.39)
SCHEMBL6981853 0.84 TRPV1 (0.42)
SCHEMBL6988884 0.82 CTSS (0.36) CTSK
SCHEMBL6985501 0.82 GCGR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed